HELLS and cancer: In nasopharyngeal carcinoma, HELLS upregulation was observed in cancerous tissues to positively correlate with advanced clinical stage and recruitment of the key epigenetic regulator G9a to suppress the activity of fumarate hydratase and drive cancer progression.16